Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)

Study Description

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

This study is designed to assess the effectiveness of the Coloplast Titan® Inflatable Penile Prosthesis (IPP) at maintaining or increasing penile length after implantation of the device. It will incorporate a modified method of cylinder sizing during implantation and a max-inflate technique after implantation.

Condition or disease	Intervention/treatment	Phase
Erectile Dysfunction	Device: Inflatable Penile Prosthesis	Not Applicable

Study Design

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Interventional (Clinical Trial)
Actual Enrollment :	40 participants
Intervention Model:	Single Group Assignment
Masking:	None (Open Label)
Primary Purpose:	Treatment
Official Title:	Prospective, Non-randomized, Multi-center Clinical Trial to Assess the Effectiveness of the Coloplast Titan® IPP at Maintaining or Increasing Penile Length After Implantation
Study Start Date :	December 2007
Actual Primary Completion Date :	May 2010
Actual Study Completion Date :	May 2011

Arms and Interventions

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm	Intervention/treatment
Titan® IPP; Subjects implanted with Titan® IPP	Device: Inflatable Penile Prosthesis; Hydraulic system designed to be surgically implanted into the penis for the management of erectile dysfunction. The implant provides the participant with voluntary control over the erect and flaccid states of the penis.; Other Name: Titan

Outcome Measures

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. The Study's Primary Objective Will Assess the Change in Penile Length. [ Time Frame: 12 months ]

Secondary Outcome Measures :

1. Assess Participant Satisfaction With the Penile Length at Baseline, 12 and 24 Months Post Implantation Via Participant Questionaire. [ Time Frame: 12 and 24 months ]
2. The Rate of Change in Male Stress Urinary Incontinence(SUI). [ Time Frame: 12 months ]

   Subject responses to 3 questions were evaluated:

   1. On average, how many of these (pads, tissues, disposable undergarments) would you use to protect against wetness during the day?
   2. Overall, how often have you needed to change your daily activities because of urinary incontinence?
   3. Overall, how big of a social problem has urinary incontinence been for you during the past month?

Eligibility Criteria

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	25 Years to 75 Years (Adult, Senior)
Sexes Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

• Has an estimated life expectancy of more than 5 years
• Has been diagnosed with erectile dysfunction
• Is willing to have the Titan IPP implanted
• Is able and willing to complete all follow-up visits and procedures indicated in this protocol
• Has been informed of the nature of the study and agrees to its provisions and - Has provided written informed consent as approved by the Institutional Review board of the respective site

Exclusion Criteria:

• Participant has had a previous penile prosthesis or prior penile enlargement surgeries
• Participant has a compromised immune system
• Participant has had a myocardial infarction or coronary artery stent placement within 2 months prior to treatment
• Participant does not have manual dexterity or mental ability to operate the pump
• Participant has an active urogenital infection or active skin infection in region of surgery
• Participant is diagnosed with fibrotic disease, such as priapism or Peyronie's disease
• Participant is diagnosed with Chordee
• Participant has neuropathy
• Participant has a serious bleeding disorder or coagulopathy

Contacts and Locations

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Locations

United States, Florida
James A Haley VA
Tampa, Florida, United States, 33612
United States, Louisiana
Regional Urology, LLC
Shreveport, Louisiana, United States, 71106
United States, Texas
University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030

Sponsors and Collaborators

Coloplast A/S

Investigators

Principal Investigator:	Gerard Henry, MD	Regional Urology, LLC
Principal Investigator:	Rafael Carrion, MD	JAames A Haley VA
Principal Investigator:	Run Wang, MD	University of Texas

More Information

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Henry GD, Carrion R, Jennermann C, Wang R. Prospective evaluation of postoperative penile rehabilitation: penile length/girth maintenance 1 year following Coloplast Titan inflatable penile prosthesis. J Sex Med. 2015 May;12(5):1298-304. doi: 10.1111/jsm.12833. Epub 2015 Apr 14.

Responsible Party:	Coloplast A/S
ClinicalTrials.gov Identifier:	NCT00731666 History of Changes
Other Study ID Numbers:	US001SU
First Posted:	August 11, 2008
Results First Posted:	November 28, 2013
Last Update Posted:	November 28, 2013
Last Verified:	September 2013

Keywords provided by Coloplast A/S:

penile length; IPP; Erectile dysfunction

Additional relevant MeSH terms:

Erectile Dysfunction; Sexual Dysfunction, Physiological; Genital Diseases, Male; Sexual Dysfunctions, Psychological; Mental Disorders